Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 2
1998 1
2002 1
2003 4
2005 1
2006 1
2007 3
2009 4
2010 5
2011 3
2012 4
2013 4
2014 3
2015 2
2016 2
2017 2
2018 4
2019 8
2020 3
2021 3
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

56 results
Results by year
Filters applied: . Clear all
Page 1
Diabetic neuropathies.
Skljarevski V, Lledo A. Skljarevski V, et al. Arch Neurol. 2006 Oct;63(10):1502-4. doi: 10.1001/archneur.63.10.1502. Arch Neurol. 2006. PMID: 17030673 No abstract available.
Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations.
Gewandter JS, Dworkin RH, Turk DC, Devine EG, Hewitt D, Jensen MP, Katz NP, Kirkwood AA, Malamut R, Markman JD, Vrijens B, Burke L, Campbell JN, Carr DB, Conaghan PG, Cowan P, Doyle MK, Edwards RR, Evans SR, Farrar JT, Freeman R, Gilron I, Juge D, Kerns RD, Kopecky EA, McDermott MP, Niebler G, Patel KV, Rauck R, Rice ASC, Rowbotham M, Sessler NE, Simon LS, Singla N, Skljarevski V, Tockarshewsky T, Vanhove GF, Wasan AD, Witter J. Gewandter JS, et al. Among authors: skljarevski v. J Pain. 2020 Sep-Oct;21(9-10):931-942. doi: 10.1016/j.jpain.2019.12.003. Epub 2019 Dec 13. J Pain. 2020. PMID: 31843583 Free PMC article. Review.
A standard database format for clinical trials of pain treatments: an ACTTION-CDISC initiative.
Dworkin RH, Allen R, Kopko S, Lu Y, Turk DC, Burke LB, Desjardins P, Etropolski M, Hewitt DJ, Jayawardena S, Lin AH, Malamut R, Michel D, Ottinger J, Peloso P, Pucino F, Rappaport BA, Skljarevski V, St Peter D, Timinski S, West CR, Wilson HD. Dworkin RH, et al. Among authors: skljarevski v. Pain. 2013 Jan;154(1):11-14. doi: 10.1016/j.pain.2012.10.014. Epub 2012 Oct 26. Pain. 2013. PMID: 23218970 Review. No abstract available.
Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.
Dworkin RH, Turk DC, Peirce-Sandner S, Burke LB, Farrar JT, Gilron I, Jensen MP, Katz NP, Raja SN, Rappaport BA, Rowbotham MC, Backonja MM, Baron R, Bellamy N, Bhagwagar Z, Costello A, Cowan P, Fang WC, Hertz S, Jay GW, Junor R, Kerns RD, Kerwin R, Kopecky EA, Lissin D, Malamut R, Markman JD, McDermott MP, Munera C, Porter L, Rauschkolb C, Rice ASC, Sampaio C, Skljarevski V, Sommerville K, Stacey BR, Steigerwald I, Tobias J, Trentacosti AM, Wasan AD, Wells GA, Williams J, Witter J, Ziegler D. Dworkin RH, et al. Among authors: skljarevski v. Pain. 2012 Jun;153(6):1148-1158. doi: 10.1016/j.pain.2012.03.003. Epub 2012 Apr 9. Pain. 2012. PMID: 22494920
A long-term open-label safety study of galcanezumab in Japanese patients with migraine.
Hirata K, Takeshima T, Sakai F, Tatsuoka Y, Suzuki N, Igarashi H, Nakamura T, Ozeki A, Yamazaki H, Skljarevski V. Hirata K, et al. Among authors: skljarevski v. Expert Opin Drug Saf. 2021 Jun;20(6):721-733. doi: 10.1080/14740338.2021.1866536. Epub 2021 Jan 4. Expert Opin Drug Saf. 2021. PMID: 33393835 Clinical Trial.
Emerging trends in the pharmacotherapy of chronic pain.
Nitu AN, Wallihan R, Skljarevski V, Ramadan NM. Nitu AN, et al. Among authors: skljarevski v. Expert Opin Investig Drugs. 2003 Apr;12(4):545-59. doi: 10.1517/13543784.12.4.545. Expert Opin Investig Drugs. 2003. PMID: 12665411 Review.
56 results